Search

Your search keyword '"Bartfai, Gyorgy"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Bartfai, Gyorgy" Remove constraint Author: "Bartfai, Gyorgy"
216 results on '"Bartfai, Gyorgy"'

Search Results

2. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

4. Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study

5. Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study

7. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

8. Low Prolactin Is Associated with Sexual Dysfunction and Psychological or Metabolic Disturbances in Middle-Aged and Elderly Men: The European Male Aging Study (EMAS)

9. Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features

10. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

11. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

12. Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men

14. Age-Related Changes in General and Sexual Health in Middle-Aged and Older Men: Results from the European Male Ageing Study (EMAS)

16. Associations Between Sex Steroids and the Development of Metabolic Syndrome: A Longitudinal Study in European Men

17. Influence of Polymorphisms in the RANKL/RANK/OPG Signaling Pathway on Volumetric Bone Mineral Density and Bone Geometry at the Forearm in Men

18. Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on Bone Health: Results from the European Male Ageing Study

19. Assessment of Sexual Health in Aging Men in Europe: Development and Validation of the European Male Ageing Study Sexual Function Questionnaire

20. Influence of Lifestyle Factors on Quantitative Heel Ultrasound Measurements in Middle-Aged and Elderly Men

21. Identification of late-onset hypogonadism in middle-aged and elderly men

22. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men

23. Comparisons of Immunoassay and Mass Spectrometry Measurements of Serum Estradiol Levels and Their Influence on Clinical Association Studies in Men

24. Cohort Profile: The European Male Ageing Study

25. Active Vitamin D (1,25-Dihydroxyvitamin D) and Bone Health in Middle-Aged and Elderly Men: The European Male Aging Study (EMAS)

26. The Relationships between Sex Hormones and Sexual Function in Middle-Aged and Older European Men

27. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: Results from two population-based cohorts

28. No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain

29. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study

30. The European Male Ageing Study (EMAS): design, methods and recruitment

32. Assessment of Sexual Health in Aging Men in Europe: Development and Validation of the European Male Ageing Study Sexual Function Questionnaire

33. The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility

34. A validation of the first genome-wide association study of calcaneus ultrasound parameters in the European Male Ageing Study

38. Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study

40. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. (Articles)

41. Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study

42. Frailty and bone health in European men

43. P2-419: Evaluation of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Cognitive Decline in the European Male Ageing Study

45. Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone levels: results from the European Male Ageing Study

47. Low free testosterone is associated with hypogonadal symptoms in men with normal total testosterone levels: results from the European Male Ageing Study

49. Characteristics and predictors of primary hypogonadism in ageing men: longitudinal data from the European Male Ageing Study

50. Frailty and bone health in European men.

Catalog

Books, media, physical & digital resources